152 related articles for article (PubMed ID: 17035228)
1. The human sef-a isoform utilizes different mechanisms to regulate receptor tyrosine kinase signaling pathways and subsequent cell fate.
Ziv I; Fuchs Y; Preger E; Shabtay A; Harduf H; Zilpa T; Dym N; Ron D
J Biol Chem; 2006 Dec; 281(51):39225-35. PubMed ID: 17035228
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity.
Preger E; Ziv I; Shabtay A; Sher I; Tsang M; Dawid IB; Altuvia Y; Ron D
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1229-34. PubMed ID: 14742870
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.
Zisman-Rozen S; Fink D; Ben-Izhak O; Fuchs Y; Brodski A; Kraus MH; Bejar J; Ron D
Oncogene; 2007 Sep; 26(41):6093-8. PubMed ID: 17420726
[TBL] [Abstract][Full Text] [Related]
4. hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling.
Xiong S; Zhao Q; Rong Z; Huang G; Huang Y; Chen P; Zhang S; Liu L; Chang Z
J Biol Chem; 2003 Dec; 278(50):50273-82. PubMed ID: 12958313
[TBL] [Abstract][Full Text] [Related]
5. Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway.
Zhang H; Zhao X; Yan L; Li M
Gynecol Oncol; 2011 Sep; 122(3):669-74. PubMed ID: 21663947
[TBL] [Abstract][Full Text] [Related]
6. hSef potentiates EGF-mediated MAPK signaling through affecting EGFR trafficking and degradation.
Ren Y; Cheng L; Rong Z; Li Z; Li Y; Zhang X; Xiong S; Hu J; Fu XY; Chang Z
Cell Signal; 2008 Mar; 20(3):518-33. PubMed ID: 18096367
[TBL] [Abstract][Full Text] [Related]
7. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
8. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
9. Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways.
Nie Y; Yang Y; Zhang J; Cai G; Chang Y; Chai G; Guo C
Biomed Pharmacother; 2017 Nov; 95():1119-1128. PubMed ID: 28922731
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
11. Delivery of the gene encoding the tumor suppressor Sef into prostate tumors by therapeutic-ultrasound inhibits both tumor angiogenesis and growth.
Mishel S; Shneyer B; Korsensky L; Goldshmidt-Tran O; Haber T; Machluf M; Ron D
Sci Rep; 2017 Nov; 7(1):15060. PubMed ID: 29118380
[TBL] [Abstract][Full Text] [Related]
12. c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation.
Kim MJ; Byun JY; Yun CH; Park IC; Lee KH; Lee SJ
Mol Cancer Res; 2008 Dec; 6(12):1872-80. PubMed ID: 19074832
[TBL] [Abstract][Full Text] [Related]
13. Sef is a spatial regulator for Ras/MAP kinase signaling.
Torii S; Kusakabe M; Yamamoto T; Maekawa M; Nishida E
Dev Cell; 2004 Jul; 7(1):33-44. PubMed ID: 15239952
[TBL] [Abstract][Full Text] [Related]
14. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
16. hSef co-localizes and interacts with Ras in the inhibition of Ras/MAPK signaling pathway.
Ren Y; Cheng L; Rong Z; Li Z; Li Y; Li H; Wang Z; Chang Z
Biochem Biophys Res Commun; 2006 Sep; 347(4):988-93. PubMed ID: 16859641
[TBL] [Abstract][Full Text] [Related]
17. Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
Darby S; Murphy T; Thomas H; Robson CN; Leung HY; Mathers ME; Gnanapragasam VJ
Br J Cancer; 2009 Dec; 101(11):1891-9. PubMed ID: 19888221
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
19. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.
Zhang L; Yang X; Li X; Li C; Zhao L; Zhou Y; Hou H
Int J Mol Med; 2015 Oct; 36(4):957-66. PubMed ID: 26310353
[TBL] [Abstract][Full Text] [Related]
20. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines.
Maeda N; Fu W; Ortin A; de las Heras M; Fan H
J Virol; 2005 Apr; 79(7):4440-50. PubMed ID: 15767444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
